Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights
Today, 8:49 AM
Gainers Vallon Pharmaceuticals (NASDAQ:VLON) stock increased by 137.8% to $0.6 during Wednesday’s regular session. Trading volume for Vallon…

ACON

Read More
5 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin
Today, 8:49 AM
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

ACMR

Read More
1 minute read
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Penny Stock OpGen Surges After UTI Panel Test Meets Primary Goal In Clinical Trial

By Vandana Singh
Today, 8:49 AM
OpGen Inc (NASDAQ:OPGN) announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.  OpGen’s Unyvero UTI Panel tests for…

OPGN

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights
Today, 8:49 AM
Gainers OpGen (NASDAQ:OPGN) stock rose 69.6% to $0.21 during Tuesday’s pre-market session. The market value of their outstanding…

AMAM

Read More
11 minute read
  • Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights
Today, 8:49 AM
  Tuesday's session saw 167 companies set new 52-week lows.

ACHL

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights
Today, 8:49 AM
Gainers Cosmos Holdings (NASDAQ:COSM) stock rose 45.1% to $0.48 during Thursday’s pre-market session. The company’s market cap stands…

AIMD

Read More
2 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Trading Ideas

Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

By Lisa Levin
Today, 8:49 AM
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday.

ADSK

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights
Today, 8:49 AM
Gainers Autolus Therapeutics (NASDAQ:AUTL) stock moved upwards by 15.0% to $2.3 during Tuesday’s after-market session. The market value…

AKLI

Read More
3 minute read
  • Biotech
  • General

OpGen Subsidiary Curetis And BioVersys Sign Collaboration Agreement For Clinical Trial Support; Unyvero Platform For Rapid Diagnostics To Be Used In Phase Ii Clinical Trial Of BV100

By Benzinga Newsdesk
Today, 8:49 AM
Unyvero platform for rapid diagnostics to be used in Phase II clinical trial of BV100   Focus on the detection of pneumonia patients infected with Acinetobacter baumannii   ROCKVILLE, Md. and BASEL,

OPGN

Read More
23 minute read
  • News
  • Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights
Today, 8:49 AM
  On Monday, 413 companies reached new 52-week lows.

AAN

Posts navigation

Previous 1 2 3 … 10 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service